MENU

QNCX Quince Therapeutics Forecast, Technical & Fundamental Analysis

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

QNCX is expected to report earnings to rise 35.92% to -17 cents per share on March 04

Quince Therapeutics QNCX Stock Earnings Reports
Q4'24
Est.
$-0.18
Q3'24
Missed
by $0.03
Q1'23
Missed
by $0.03
Q4'22
Beat
by $0.14
Q3'22
Beat
by $0.06
The last earnings report on November 13 showed earnings per share of -12 cents, missing the estimate of -10 cents. With 168.42K shares outstanding, the current market capitalization sits at 81.40M.
A.I. Advisor
published General Information

General Information

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

QNCX and Stocks

Correlation & Price change

A.I.dvisor tells us that QNCX and KOD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNCX and KOD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-3.66%
KOD - QNCX
28%
Poorly correlated
+9.24%
MNPR - QNCX
27%
Poorly correlated
+14.91%
LQDA - QNCX
24%
Poorly correlated
+2.54%
MDXG - QNCX
24%
Poorly correlated
+0.63%
FENC - QNCX
22%
Poorly correlated
+2.02%
More